Publications by authors named "Chad Barnett"

Claim this Profile
T
Timely Genetic Testing and Therapy Management in Patients With g-Mutated Metastatic Breast Cancer Receiving Talazoparib.
Ashley Martinez, Tiffany Jones, Joanne C Ryan, Chad M Barnett, Elpitha L Soussou

J Adv Pract Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer.
Naoko Matsuda, Xiaoping Wang, Bora Lim, Savitri Krishnamurthy, Ricardo H Alvarez, Chad M Barnett

JAMA Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes.
Takahiro Kogawa, Takeo Fujii, Tamer M Fouad, Diane D Liu, Kenichi Harano, Chad Barnett

Breast Cancer Res Treat· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe hyponatremia following cyclophosphamide infusion in breast cancer patients.
Katherine Clifton, Chad Barnett, Ashley Martinez, Meghan Karuturi, Sadia Saleem

Breast J· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future.
Adam J DiPippo, Neelam K Patel, Chad M Barnett

Pharmacotherapy· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer.
Jessica M Baron, Bonnie L Boster, Chad M Barnett

J Oncol Pharm Pract· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of children exposed in utero to chemotherapy for breast cancer.
Rashmi K Murthy, Richard L Theriault, Chad M Barnett, Silvia Hodge, Mildred M Ramirez

Breast Cancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, risk factors, and management of infusion-related reactions in breast cancer patients receiving trastuzumab.
Lisa M Thompson, Karen Eckmann, Bonnie L Boster, Kenneth R Hess, Laura B Michaud, Chad M Barnett

Oncologist· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pertuzumab: a new targeted therapy for HER2-positive metastatic breast cancer.
Stephanie J Malenfant, Karen R Eckmann, Chad M Barnett

Pharmacotherapy· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer.
Jennifer K Litton, Carla L Warneke, Karin M Hahn, Shana L Palla, Henry M Kuerer, Chad Barnett

Oncologist· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of pharmacist-provided medication therapy management services in an oncology ambulatory setting.
Jack L Watkins, Andrea Landgraf, Chad M Barnett, Laura Michaud

J Am Pharm Assoc (2003)· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus: targeted therapy on the horizon for the treatment of breast cancer.
Chad M Barnett

Pharmacotherapy· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.
Kellie L Jones, Chad Barnett, Michelle Gauthier, Bonnie Boster, Janet L Espirito

J Oncol Pharm Pract· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival data of patients with anthracycline- or taxane-pretreated or resistant metastatic breast cancer.
Chad M Barnett

Pharmacotherapy· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.
Sao Jiralerspong, Shana L Palla, Sharon H Giordano, Funda Meric-Bernstam, Cornelia Liedtke, Chad M Barnett

J Clin Oncol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis